FibroBiologics Inc (NASDAQ:FBLG) price on Thursday, July 03, rose 0.29% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.61.
A look at the stock’s price movement, the close in the last trading session was $0.61, moving within a range at $0.6016 and $0.6486. Turning to its 52-week performance, $5.62 and $0.59 were the 52-week high and 52-week low respectively. Overall, FBLG moved -22.38% over the past month.
FibroBiologics Inc’s market cap currently stands at around $23.42 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that FBLG is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
FBLG’s current price about -19.31% and -28.98% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 32.16, while 7-day volatility ratio is 10.14% and 9.84% in the 30-day chart. Further, FibroBiologics Inc (FBLG) has a beta value of -0.82. Analysts have given the company’s stock an average 52-week price target of $9, forecast between a low of $9 and high of $9. Looking at the price targets, the low is -1375.41% off current price level while to achieve the yearly target high, price needs to move -1375.41%. Nonetheless, investors will most likely welcome a -1375.41% jump to $9 which is the analysts’ median price.
If we refocus on FibroBiologics Inc (NASDAQ:FBLG), historical trading data shows that trading volumes averaged 0.73 over the past 10 days and 320.77K over the past 3 months. The company’s latest data on shares outstanding shows there are 37.74 million shares.
The 28.35% of FibroBiologics Inc’s shares are in the hands of company insiders while institutional holders own 16.80% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.35 million on 2025-06-13, giving us a short ratio of 5.08. The data shows that as of 2025-06-13 short interest in FibroBiologics Inc (FBLG) stood at 405.99998 of shares outstanding, with shares short falling to 1.57 million registered in 2025-05-15. Current price change has pushed the stock -84.70% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the FBLG stock continues to rise going into the next quarter.
